Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Design of Experiment (DOE) Utilization to Develop a Simple and Robust Reversed-Phase HPLC Technique for Related Substances' Estimation of Omeprazole Formulations.

Scientia pharmaceutica

Manranjan VC, Yadav DS, Jogia HA, Chauhan PL.
PMID: 24482772
Sci Pharm. 2013 Aug 12;81(4):1043-56. doi: 10.3797/scipharm.1306-06. Print 2013.

A simple, fast, and sensitive reversed-phase HPLC method with UV detection was developed for the quantitation of omeprazole and its eleven related compounds (impurities) in pharmaceutical formulation using the Thermo Accucore C-18 (50 mm × 4.6 mm, 2.6 μm)...

Cite
Manranjan VC, Yadav DS, Jogia HA, et al. Design of Experiment (DOE) Utilization to Develop a Simple and Robust Reversed-Phase HPLC Technique for Related Substances' Estimation of Omeprazole Formulations. Sci Pharm. 2013;81(4):1043-56doi: 10.3797/scipharm.1306-06.
Manranjan, V. C., Yadav, D. S., Jogia, H. A., & Chauhan, P. L. (2013). Design of Experiment (DOE) Utilization to Develop a Simple and Robust Reversed-Phase HPLC Technique for Related Substances' Estimation of Omeprazole Formulations. Scientia pharmaceutica, 81(4), 1043-56. https://doi.org/10.3797/scipharm.1306-06
Manranjan, Vayeda Chintan, et al. "Design of Experiment (DOE) Utilization to Develop a Simple and Robust Reversed-Phase HPLC Technique for Related Substances' Estimation of Omeprazole Formulations." Scientia pharmaceutica vol. 81,4 (2013): 1043-56. doi: https://doi.org/10.3797/scipharm.1306-06
Manranjan VC, Yadav DS, Jogia HA, Chauhan PL. Design of Experiment (DOE) Utilization to Develop a Simple and Robust Reversed-Phase HPLC Technique for Related Substances' Estimation of Omeprazole Formulations. Sci Pharm. 2013 Aug 12;81(4):1043-56. doi: 10.3797/scipharm.1306-06. Print 2013. PMID: 24482772; PMCID: PMC3867239.
Copy Download .nbib Format: NLM
Erratum to: CBP binding outside of promoters and enhancers in Drosophila melanogaster.

Epigenetics & chromatin

Philip P, Boija A, Vaid R, Churcher AM, Meyers DJ, Cole PA, Mannervik M, Stenberg P.
PMID: 27625704
Epigenetics Chromatin. 2016 Sep 12;9(1):38. doi: 10.1186/s13072-016-0088-y. eCollection 2016.

[This corrects the article DOI: 10.1186/s13072-015-0042-4.].

Cite
Philip P, Boija A, Vaid R, et al. Erratum to: CBP binding outside of promoters and enhancers in Drosophila melanogaster. Epigenetics Chromatin. 2016;9(1):38doi: 10.1186/s13072-016-0088-y.
Philip, P., Boija, A., Vaid, R., Churcher, A. M., Meyers, D. J., Cole, P. A., Mannervik, M., & Stenberg, P. (2016). Erratum to: CBP binding outside of promoters and enhancers in Drosophila melanogaster. Epigenetics & chromatin, 9(1), 38. https://doi.org/10.1186/s13072-016-0088-y
Philip, Philge, et al. "Erratum to: CBP binding outside of promoters and enhancers in Drosophila melanogaster." Epigenetics & chromatin vol. 9,1 (2016): 38. doi: https://doi.org/10.1186/s13072-016-0088-y
Philip P, Boija A, Vaid R, Churcher AM, Meyers DJ, Cole PA, Mannervik M, Stenberg P. Erratum to: CBP binding outside of promoters and enhancers in Drosophila melanogaster. Epigenetics Chromatin. 2016 Sep 12;9(1):38. doi: 10.1186/s13072-016-0088-y. eCollection 2016. PMID: 27625704; PMCID: PMC5020526.
Copy Download .nbib Format: NLM
Colloidally Stable Monolayer Nanosheets with Colorimetric Responses.

Small (Weinheim an der Bergstrasse, Germany)

Hu B, Sun S, Wu B, Wu P.
PMID: 30589208
Small. 2019 Feb;15(5):e1804975. doi: 10.1002/smll.201804975. Epub 2018 Dec 27.

Despite the discovery of chromogenic-layered materials for decades of years, fabrication of colloidally stable monolayer organic 2D nanosheets in aqueous media with colorimetric responses is still challenging. Herein reported is the first solution synthesis of chromic monolayer nanosheets via...

Cite
Hu B, Sun S, Wu B, et al. Colloidally Stable Monolayer Nanosheets with Colorimetric Responses. Small. 2018;15(5):e1804975doi: 10.1002/smll.201804975.
Hu, B., Sun, S., Wu, B., & Wu, P. (2019). Colloidally Stable Monolayer Nanosheets with Colorimetric Responses. Small (Weinheim an der Bergstrasse, Germany), 15(5), e1804975. https://doi.org/10.1002/smll.201804975
Hu, Bojian, et al. "Colloidally Stable Monolayer Nanosheets with Colorimetric Responses." Small (Weinheim an der Bergstrasse, Germany) vol. 15,5 (2019): e1804975. doi: https://doi.org/10.1002/smll.201804975
Hu B, Sun S, Wu B, Wu P. Colloidally Stable Monolayer Nanosheets with Colorimetric Responses. Small. 2019 Feb;15(5):e1804975. doi: 10.1002/smll.201804975. Epub 2018 Dec 27. PMID: 30589208.
Copy Download .nbib Format: NLM
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.

Brain : a journal of neurology

Magusali N, Graham AC, Piers TM, Panichnantakul P, Yaman U, Shoai M, Reynolds RH, Botia JA, Brookes KJ, Guetta-Baranes T, Bellou E, Bayram S, Sokolova D, Ryten M, Sala Frigerio C, Escott-Price V, Morgan K, Pocock JM, Hardy J, Salih DA.
PMID: 34619763
Brain. 2021 Dec 31;144(12):3727-3741. doi: 10.1093/brain/awab337.

Recently, we reported oligoadenylate synthetase 1 (OAS1) contributed to the risk of Alzheimer's disease, by its enrichment in transcriptional networks expressed by microglia. However, the function of OAS1 within microglia was not known. Using genotyping from 1313 individuals with...

Cite
Magusali N, Graham AC, Piers TM, et al. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain. 2021;144(12):3727-3741doi: 10.1093/brain/awab337.
Magusali, N., Graham, A. C., Piers, T. M., Panichnantakul, P., Yaman, U., Shoai, M., Reynolds, R. H., Botia, J. A., Brookes, K. J., Guetta-Baranes, T., Bellou, E., Bayram, S., Sokolova, D., Ryten, M., Sala Frigerio, C., Escott-Price, V., Morgan, K., Pocock, J. M., Hardy, J., & Salih, D. A. (2021). A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain : a journal of neurology, 144(12), 3727-3741. https://doi.org/10.1093/brain/awab337
Magusali, Naciye, et al. "A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene." Brain : a journal of neurology vol. 144,12 (2021): 3727-3741. doi: https://doi.org/10.1093/brain/awab337
Magusali N, Graham AC, Piers TM, Panichnantakul P, Yaman U, Shoai M, Reynolds RH, Botia JA, Brookes KJ, Guetta-Baranes T, Bellou E, Bayram S, Sokolova D, Ryten M, Sala Frigerio C, Escott-Price V, Morgan K, Pocock JM, Hardy J, Salih DA. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain. 2021 Dec 31;144(12):3727-3741. doi: 10.1093/brain/awab337. PMID: 34619763; PMCID: PMC8500089.
Copy Download .nbib Format: NLM
Comparison of Hemodynamic Visualization in Cerebral Arteries: Can Magnetic Resonance Imaging Replace Computational Fluid Dynamics?.

Journal of personalized medicine

Ngo MT, Lee UY, Ha H, Jin N, Chung GH, Kwak YG, Jung J, Kwak HS.
PMID: 33808514
J Pers Med. 2021 Mar 30;11(4). doi: 10.3390/jpm11040253.

A multimodality approach was applied using four-dimensional flow magnetic resonance imaging (4D flow MRI), time-of-flight magnetic resonance angiography (TOF-MRA) signal intensity gradient (SIG), and computational fluid dynamics (CFD) to investigate the 3D blood flow characteristics and wall shear stress...

Cite
Ngo MT, Lee UY, Ha H, et al. Comparison of Hemodynamic Visualization in Cerebral Arteries: Can Magnetic Resonance Imaging Replace Computational Fluid Dynamics?. J Pers Med. 2021;11(4)doi: 10.3390/jpm11040253.
Ngo, M. T., Lee, U. Y., Ha, H., Jin, N., Chung, G. H., Kwak, Y. G., Jung, J., & Kwak, H. S. (2021). Comparison of Hemodynamic Visualization in Cerebral Arteries: Can Magnetic Resonance Imaging Replace Computational Fluid Dynamics?. Journal of personalized medicine, 11(4), . https://doi.org/10.3390/jpm11040253
Ngo, Minh Tri, et al. "Comparison of Hemodynamic Visualization in Cerebral Arteries: Can Magnetic Resonance Imaging Replace Computational Fluid Dynamics?." Journal of personalized medicine vol. 11,4 (2021). doi: https://doi.org/10.3390/jpm11040253
Ngo MT, Lee UY, Ha H, Jin N, Chung GH, Kwak YG, Jung J, Kwak HS. Comparison of Hemodynamic Visualization in Cerebral Arteries: Can Magnetic Resonance Imaging Replace Computational Fluid Dynamics?. J Pers Med. 2021 Mar 30;11(4). doi: 10.3390/jpm11040253. PMID: 33808514; PMCID: PMC8066205.
Copy Download .nbib Format: NLM
Interfacial Activity of Lipoprotein (a) Isoforms with a Variable Number of Kringle IV Type 2 Repeats: A New Indicator of Cardiovascular Risk?.

Annals of clinical and laboratory science

Santonastaso A, Boria A, Paboeuf G, Beaufils S, Bolanos-Garcia VM, Vié V, Scotti C.
PMID: 34921033
Ann Clin Lab Sci. 2021 Nov;51(6):795-804.

OBJECTIVE: Lipoprotein (a) [Lp(a)] is an LDL-like particle constituted by lipids, apolipoprotein B100 and apolipoprotein (a) [apo(a)], a multidomain glycoprotein whose molecular mass is dependent on the genetically encoded number of Kringle IV type 2 (KIV-2) repeats. Because Lp(a)...

Cite
Santonastaso A, Boria A, Paboeuf G, et al. Interfacial Activity of Lipoprotein (a) Isoforms with a Variable Number of Kringle IV Type 2 Repeats: A New Indicator of Cardiovascular Risk?. Ann Clin Lab Sci. 2021;51(6):795-804
Santonastaso, A., Boria, A., Paboeuf, G., Beaufils, S., Bolanos-Garcia, V. M., Vié, V., & Scotti, C. (2021). Interfacial Activity of Lipoprotein (a) Isoforms with a Variable Number of Kringle IV Type 2 Repeats: A New Indicator of Cardiovascular Risk?. Annals of clinical and laboratory science, 51(6), 795-804.
Santonastaso, Alice, et al. "Interfacial Activity of Lipoprotein (a) Isoforms with a Variable Number of Kringle IV Type 2 Repeats: A New Indicator of Cardiovascular Risk?." Annals of clinical and laboratory science vol. 51,6 (2021): 795-804.
Santonastaso A, Boria A, Paboeuf G, Beaufils S, Bolanos-Garcia VM, Vié V, Scotti C. Interfacial Activity of Lipoprotein (a) Isoforms with a Variable Number of Kringle IV Type 2 Repeats: A New Indicator of Cardiovascular Risk?. Ann Clin Lab Sci. 2021 Nov;51(6):795-804. PMID: 34921033.
Copy Download .nbib Format: NLM
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.

Brain : a journal of neurology

Magusali N, Graham AC, Piers TM, Panichnantakul P, Yaman U, Shoai M, Reynolds RH, Botia JA, Brookes KJ, Guetta-Baranes T, Bellou E, Bayram S, Sokolova D, Ryten M, Sala Frigerio C, Escott-Price V, Morgan K, Pocock JM, Hardy J, Salih DA.
PMID: 34619763
Brain. 2021 Oct 07; doi: 10.1093/brain/awab337. Epub 2021 Oct 07.

Recently, we reported oligoadenylate synthetase 1 (OAS1) contributed to the risk of Alzheimer's disease, by its enrichment in transcriptional networks expressed by microglia. However, the function of OAS1 within microglia was not known. Using genotyping from 1313 individuals with...

Cite
Magusali N, Graham AC, Piers TM, et al. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain. 2021;doi: 10.1093/brain/awab337.
Magusali, N., Graham, A. C., Piers, T. M., Panichnantakul, P., Yaman, U., Shoai, M., Reynolds, R. H., Botia, J. A., Brookes, K. J., Guetta-Baranes, T., Bellou, E., Bayram, S., Sokolova, D., Ryten, M., Sala Frigerio, C., Escott-Price, V., Morgan, K., Pocock, J. M., Hardy, J., & Salih, D. A. (2021). A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain : a journal of neurology, . https://doi.org/10.1093/brain/awab337
Magusali, Naciye, et al. "A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene." Brain : a journal of neurology vol. (2021). doi: https://doi.org/10.1093/brain/awab337
Magusali N, Graham AC, Piers TM, Panichnantakul P, Yaman U, Shoai M, Reynolds RH, Botia JA, Brookes KJ, Guetta-Baranes T, Bellou E, Bayram S, Sokolova D, Ryten M, Sala Frigerio C, Escott-Price V, Morgan K, Pocock JM, Hardy J, Salih DA. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain. 2021 Oct 07; doi: 10.1093/brain/awab337. Epub 2021 Oct 07. PMID: 34619763; PMCID: PMC8500089.
Copy Download .nbib Format: NLM
Extraction of Essential Oils of .

TheScientificWorldJournal

Elyemni M, Louaste B, Nechad I, Elkamli T, Bouia A, Taleb M, Chaouch M, Eloutassi N.
PMID: 31057339
ScientificWorldJournal. 2019 Apr 01;2019:3659432. doi: 10.1155/2019/3659432. eCollection 2019.

The extraction of essential oils is generally carried out by two main techniques: azeotropic distillation (hydrodistillation, hydrodiffusion, and steam distillation) and extraction with solvents. However, these traditional methods are a bit expensive, especially since they are extremely energy and...

Cite
Elyemni M, Louaste B, Nechad I, et al. Extraction of Essential Oils of . ScientificWorldJournal. 2019;2019:3659432doi: 10.1155/2019/3659432.
Elyemni, M., Louaste, B., Nechad, I., Elkamli, T., Bouia, A., Taleb, M., Chaouch, M., & Eloutassi, N. (2019). Extraction of Essential Oils of . TheScientificWorldJournal, 20193659432. https://doi.org/10.1155/2019/3659432
Elyemni, Majda, et al. "Extraction of Essential Oils of ." TheScientificWorldJournal vol. 2019 (2019): 3659432. doi: https://doi.org/10.1155/2019/3659432
Elyemni M, Louaste B, Nechad I, Elkamli T, Bouia A, Taleb M, Chaouch M, Eloutassi N. Extraction of Essential Oils of . ScientificWorldJournal. 2019 Apr 01;2019:3659432. doi: 10.1155/2019/3659432. eCollection 2019. PMID: 31057339; PMCID: PMC6463580.
Copy Download .nbib Format: NLM
Pituitary dysfunction and association with fatigue in stroke and other acute brain injury.

Endocrine connections

Booij HA, Gaykema WDC, Kuijpers KAJ, Pouwels MJM, den Hertog HM.
PMID: 29748174
Endocr Connect. 2018 Jun;7(6):R223-R237. doi: 10.1530/EC-18-0147. Epub 2018 May 10.

BACKGROUND: Poststroke fatigue (PSF) is a highly prevalent and debilitating condition. However, the etiology remains incompletely understood. Literature suggests the co-prevalence of pituitary dysfunction (PD) with stroke, and the question raises whether this could be a contributing factor to...

Cite
Booij HA, Gaykema WDC, Kuijpers KAJ, et al. Pituitary dysfunction and association with fatigue in stroke and other acute brain injury. Endocr Connect. 2018;7(6):R223-R237doi: 10.1530/EC-18-0147.
Booij, H. A., Gaykema, W. D. C., Kuijpers, K. A. J., Pouwels, M. J. M., & den Hertog, H. M. (2018). Pituitary dysfunction and association with fatigue in stroke and other acute brain injury. Endocrine connections, 7(6), R223-R237. https://doi.org/10.1530/EC-18-0147
Booij, H A, et al. "Pituitary dysfunction and association with fatigue in stroke and other acute brain injury." Endocrine connections vol. 7,6 (2018): R223-R237. doi: https://doi.org/10.1530/EC-18-0147
Booij HA, Gaykema WDC, Kuijpers KAJ, Pouwels MJM, den Hertog HM. Pituitary dysfunction and association with fatigue in stroke and other acute brain injury. Endocr Connect. 2018 Jun;7(6):R223-R237. doi: 10.1530/EC-18-0147. Epub 2018 May 10. PMID: 29748174; PMCID: PMC6000755.
Copy Download .nbib Format: NLM
CBP binding outside of promoters and enhancers in Drosophila melanogaster.

Epigenetics & chromatin

Philip P, Boija A, Vaid R, Churcher AM, Meyers DJ, Cole PA, Mannervik M, Stenberg P.
PMID: 26604986
Epigenetics Chromatin. 2015 Nov 24;8:48. doi: 10.1186/s13072-015-0042-4. eCollection 2015.

BACKGROUND: CREB-binding protein (CBP, also known as nejire) is a transcriptional co-activator that is conserved in metazoans. CBP plays an important role in embryonic development and cell differentiation and mutations in CBP can lead to various diseases in humans....

Cite
Philip P, Boija A, Vaid R, et al. CBP binding outside of promoters and enhancers in Drosophila melanogaster. Epigenetics Chromatin. 2015;8:48doi: 10.1186/s13072-015-0042-4.
Philip, P., Boija, A., Vaid, R., Churcher, A. M., Meyers, D. J., Cole, P. A., Mannervik, M., & Stenberg, P. (2015). CBP binding outside of promoters and enhancers in Drosophila melanogaster. Epigenetics & chromatin, 848. https://doi.org/10.1186/s13072-015-0042-4
Philip, Philge, et al. "CBP binding outside of promoters and enhancers in Drosophila melanogaster." Epigenetics & chromatin vol. 8 (2015): 48. doi: https://doi.org/10.1186/s13072-015-0042-4
Philip P, Boija A, Vaid R, Churcher AM, Meyers DJ, Cole PA, Mannervik M, Stenberg P. CBP binding outside of promoters and enhancers in Drosophila melanogaster. Epigenetics Chromatin. 2015 Nov 24;8:48. doi: 10.1186/s13072-015-0042-4. eCollection 2015. PMID: 26604986; PMCID: PMC4657240.
Copy Download .nbib Format: NLM
Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region.

Clinical ophthalmology (Auckland, N.Z.)

Wei W, Chen Y, Hu B, Zhao M, Han M, Dai H, Uy HS, Chen MY, Wang K, Jiao J, Lou J, Li XY.
PMID: 34675477
Clin Ophthalmol. 2021 Oct 13;15:4097-4108. doi: 10.2147/OPTH.S325618. eCollection 2021.

PURPOSE: To evaluate the safety and efficacy of dexamethasone intravitreal implant 0.7 mg (DEX) compared with laser photocoagulation in patients with diabetic macular edema (DME).PATIENTS AND METHODS: This Phase 3, multicenter, randomized, efficacy evaluator-masked, parallel-group, 12-month clinical study enrolled...

Cite
Wei W, Chen Y, Hu B, et al. Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region. Clin Ophthalmol. 2021;15:4097-4108doi: 10.2147/OPTH.S325618.
Wei, W., Chen, Y., Hu, B., Zhao, M., Han, M., Dai, H., Uy, H. S., Chen, M. Y., Wang, K., Jiao, J., Lou, J., & Li, X. Y. (2021). Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region. Clinical ophthalmology (Auckland, N.Z.), 154097-4108. https://doi.org/10.2147/OPTH.S325618
Wei, Wenbin, et al. "Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region." Clinical ophthalmology (Auckland, N.Z.) vol. 15 (2021): 4097-4108. doi: https://doi.org/10.2147/OPTH.S325618
Wei W, Chen Y, Hu B, Zhao M, Han M, Dai H, Uy HS, Chen MY, Wang K, Jiao J, Lou J, Li XY. Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region. Clin Ophthalmol. 2021 Oct 13;15:4097-4108. doi: 10.2147/OPTH.S325618. eCollection 2021. PMID: 34675477; PMCID: PMC8520964.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in bioengineering and biotechnology

Ha H, Huh HK, Park KJ, Dyverfeldt P, Ebbers T, Kim DH, Yang DH.
PMID: 34950643
Front Bioeng Biotechnol. 2021 Dec 07;9:774954. doi: 10.3389/fbioe.2021.774954. eCollection 2021.

Imaging hemodynamics play an important role in the diagnosis of abnormal blood flow due to vascular and valvular diseases as well as in monitoring the recovery of normal blood flow after surgical or interventional treatment. Recently, characterization of turbulent...

Cite
Ha H, Huh HK, Park KJ, et al. . Front Bioeng Biotechnol. 2021;9:774954doi: 10.3389/fbioe.2021.774954.
Ha, H., Huh, H. K., Park, K. J., Dyverfeldt, P., Ebbers, T., Kim, D. H., & Yang, D. H. (2021). . Frontiers in bioengineering and biotechnology, 9774954. https://doi.org/10.3389/fbioe.2021.774954
Ha, Hojin, et al. "." Frontiers in bioengineering and biotechnology vol. 9 (2021): 774954. doi: https://doi.org/10.3389/fbioe.2021.774954
Ha H, Huh HK, Park KJ, Dyverfeldt P, Ebbers T, Kim DH, Yang DH. . Front Bioeng Biotechnol. 2021 Dec 07;9:774954. doi: 10.3389/fbioe.2021.774954. eCollection 2021. PMID: 34950643; PMCID: PMC8691458.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries